Gut Liver.
2022 Nov;16(6):907-920. 10.5009/gnl210299.
Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
- Hong SW
1,2 - Ye BD1,2,3
- Cheon JH4
- Lee JH5
- Koo JS6
- Jang BI7
- Lee KM8
- Kim YS9
- Kim TO10
- Im JP11
- Song GA12
- Jung SA13
- Kim HS14
- Park DI15
- Kim HS16
- Huh KC17
- Kim YH18
- Cha JM19
- Seo GS20
- Choi CH21
- Song HJ22
- Baik GH23
- Kim JW24
- Shin SJ25
- Park YS26
- Lee CK27
- Lee J28
- Jung SH29
- Jung Y30
- Park SC31
- Joo YE14
- Jeen YT32
- Han DS33
- Yang SK1,2,3
- Kim HJ27
- Kim WH4
- Kim JS11
- Affiliations
-
- 1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- 2Digestive Diseases Research Center, University of Ulsan College of Medicine, Seoul, Korea.
- 3Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- 4Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
- 5Digestive Endoscopic Center, Seoul Song Do Colorectal Hospital, Seoul, Korea.
- 6Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Ansan, Korea.
- 7Division of Gastroenterology and Hepatology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.
- 8Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
- 9Department of Internal Medicine, Inje University Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
- 10Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
- 11Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- 12Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.
- 13Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
- 14Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
- 15Division of Gastroenterology, Department of Internal Medicine and Gastrointestinal Cancer Center, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 16Division of Gastroenterology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
- 17Division of Gastroenterology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.
- 18Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 19Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.
- 20Department of Internal Medicine, Digestive Disease Research Institute, Wonkwang University College of Medicine, Iksan, Korea.
- 21Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
- 22Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Korea.
- 23Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
- 24Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul National University of College of Medicine, Seoul, Korea.
- 25Department of Gastroenterology, Ajou University School of Medicine, Suwon, Korea.
- 26Division of Gastroenterology, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
- 27Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
- 28Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea.
- 29Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University College of Medicine, Daejeon, Korea.
- 30Department of Internal Medicine, Soonchunhyang University College of Medicine, Cheonan, Korea.
- 31Division of Gastroenterology and Hepatology, Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
- 32Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
- 33Division of Gastroenterology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
- KMID: 2535194
- DOI: http://doi.org/10.5009/gnl210299
Abstract
- Background/Aims
The prospective Crohn’s Disease Clinical Network and Cohort Study is a nationwide multicenter cohort study of patients with Crohn’s disease (CD) in Korea, aiming to prospectively investigate the clinical features and long-term prognosis associated with CD.
Methods
Patients diagnosed with CD between January 2009 and September 2019 were prospectively enrolled. They were divided into two cohorts according to the year of diagnosis: cohort 1 (diagnosed between 2009 and 2011) versus cohort 2 (between 2012 and 2019).
Results
A total of 1,175 patients were included, and the median follow-up duration was 68 months (interquartile range, 39.0 to 91.0 months). The treatment-free durations for thiopurines (p<0.001) and anti-tumor necrosis factor agents (p=0.018) of cohort 2 were shorter than those of cohort 1. Among 887 patients with B1 behavior at diagnosis, 149 patients (16.8%) progressed to either B2 or B3 behavior during follow-up. Early use of thiopurine was associated with a reduced risk of behavioral progression (adjusted hazard ratio [aHR], 0.69; 95% confidence interval [CI], 0.50 to 0.90), and family history of inflammatory bowel disease was associated with an increased risk of behavioral progression (aHR, 2.29; 95% CI, 1.16 to 4.50). One hundred forty-one patients (12.0%) underwent intestinal resection, and the intestinal resection-free survival time was significantly longer in cohort 2 than in cohort 1 (p=0.003). The early use of thiopurines (aHR, 0.35; 95% CI, 0.23 to 0.51) was independently associated with a reduced risk of intestinal resection.
Conclusions
The prognosis of CD in Korea appears to have improved over time, as evidenced by the decreasing intestinal resection rate. Early use of thiopurines was associated with an improved prognosis represented by a reduced risk of intestinal resection.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Characteristics of Korean Patients with Elderly-Onset Crohn’s Disease: Results from the Prospective CONNECT Study
- Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors
- A Case of Crohn's Disease Confined to the Appendix
- Idiopathic Granulomatous Appendicitis: A case report
- Correlation Between Anastomotic Configuration and Long-term Outcomes in Surgery for Crohn Disease
